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Integration of HIV-1 linear DNA into the host chromatin is an
essential step in the viral life cycle. However, the majority of
reverse-transcribed, nuclear-imported viral genomes remain epi-
somal, either as linear or circular DNA. To date, these noninte-
grated viral genomes are largely considered ‘‘dead-end products’’
of reverse transcription. Indeed, limited gene expression from
nonintegrated HIV-1 has been reported, although the mechanism
that renders nonintegrating HIV-1 genomes incapable of support-
ing efficient viral replication has not been fully elucidated. Here,
we demonstrate that nonintegrating HIV-1 and HIV-1-based vector
genomes are organized into chromatin structures and enriched
with histone modifications typical of transcriptionally silenced
chromatin. Gene expression and replication of nonintegrating
HIV-1 was notably increased in vitro upon exposure to histone
deacetylase inhibitors (HDACi) in the form of various short-chain
fatty acids (SCFAs) known to be endogenously produced by normal
microbial-gut flora. Furthermore, we demonstrated genetic and
functional crosstalk between episomal and integrated vector/viral
genomes, resulting in recombination between integrated and non-
integrated HIV-1, as well as mobilization of episomal vector genomes
by productive viral particles encoded by integrated viral genomes.
Finally, we propose a mechanism describing the role of episomal
HIV-1 forms in the viral life cycle in a SCFA-rich gut environment.
episomal expression  HDAC inhibitors  histone modifications
In contradiction to the central role of integration in the HIV-1 lifecycle, the majority of viral genomes remain episomal after nuclear
import, either as linear or circular DNA (1). The passive, yet rapid,
loss of episomal HIV-1 forms in dividing cells, such as activated T
cells, is only part of a complex mechanism rendering nonintegrating
HIV-1 forms replication-defective. This view is premised on a
number of in vitro studies demonstrating the stability of circular
HIV-1 episomes in T cell lines and the persistence of integrase-
deficient HIV-1 in nondividing primary macrophages (2, 3). Sup-
porting this notion are early reports describing the accumulation of
episomal HIV-1 forms in the brain tissue of AIDS patients and
more recent studies demonstrating the persistence of nonintegrat-
ing HIV-1 vector forms in various rodent tissues in vivo (4).
Surprisingly, a study by Cara et al. described the replication of
integrase-deficient HIV-1 in primary macrophages (5). However,
this report is in contrast to a large body of studies from several
research groups that demonstrated fundamental differences in the
level and regulation of gene expression from episomal and inte-
grated HIV-1 genomes (3, 6). These studies imply that altered viral
gene expression from HIV-1 forms may be involved in the mech-
anism that renders nonintegrating HIV-1 replication-defective. In
fact, the use of integrase-deficient, HIV-1-containing reporter
genes in place of early or late proteins (nef, gag) demonstrated that
episomal HIV-1 lacks the capability to express proteins encoded by
either unspliced or fully spliced viral mRNAs in CD4-positive cells
(7, 8). Conversely, expression of env-, tat-, and nef-encoding
mRNAs from nonintegrating HIV-1 was observed, although only
the fully spliced mRNAs were translated to nef and tat proteins (9).
Furthermore, episomal expression has been reported in a cell
line-dependent manner (2, 6). Importantly, the level of episomal nef
expression was sufficient to downregulate CD4 expression on host
cell surfaces and to induce T cell activation (2). These findings
suggest that gene expression from nonintegrating HIV-1 forms can
potentially affect the life cycle and pathogenesis of HIV-1. This
notion was corroborated by a recent report showing the ability of
integrated HIV-1 provirus to support packaging of episomally
transcribed viral genomes into infectious particles (7).
A recent report by Bayer et al. showed a significant reduction in
transgene expression from an internal CMV promoter in noninte-
grating self-inactivating (SIN) HIV-1 vectors in comparison with
their integrated counterparts (10). Furthermore, a minimal dele-
tion in the vector’s U3 region dramatically reduced transcription
from an internal CMV promoter in episomal vectors, yet had no
effect on transgene expression from identical integrated vectors.
These findings raise the possibility that the observed differences in
proviral and episomal HIV-1 gene expression are analogous to the
differences observed in gene expression following stable and tran-
sient transfection of gene-expression cassettes containing retroviral
LTRs (11). Importantly, several reports have shown that the
genomes of DNA viruses, including SV40, EBV, HSV, AAV, and
HBV, are organized into chromatin-like structures, which have
major effects on viral gene expression and life cycle (12–15).
Interestingly, a recent study demonstrated that the transcriptional
characteristics of episomal HIV-1 forms generated in the course of
transduction significantly differ from those of transiently trans-
fected DNA (16). Ma et al., in showing the ability of SIN and
non-SIN single-LTR plasmids to support the production of high-
titer vector particles following transient transfection, corroborated
this notion (17). Notwithstanding these reports, the possibility that
the replication deficiency of the episomal majority of HIV-1
genomes may be partly due to a repressive chromatin structure has
not been tested.
In this study, we demonstrate that episomal HIV-1 and HIV-1
vectors are associated with histones and organized into chromatin
structures typical of silent chromatin. Furthermore, gene expression
from the viral episomes was increased significantly upon exposure
to histone deacetylase inhibitors (HDACi) in the form of short-
chain fatty acids (SCFAs), some of which are known bacterial
metabolites generated in large quantities by the normal gut flora.
In addition, we demonstrated crosstalk between episomes and
integrase-proficient HIV-1, resulting in mobilization of episomal
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vectors and genetic complementation of envelope-deficient HIV-1.
Premised on these findings, we suggest that episomal HIV-1
genomes have a significant role in the viral life cycle, especially in
such early stages as establishing productive infection in the gut.
Results
Promoter-Independent Silencing of Episomal HIV-1 Vectors. A recent
study demonstrating downregulation of transcription from nonin-
tegrating HIV-1 vectors carrying an internal CMV promoter im-
plied that transcriptional silencing might be inherent to episomal
HIV-1 vector forms (10). To rule out the possibility that the
observed low level of episomal transgene expression stemmed from
CMV promoter susceptibility to silencing, we used FACScan
analysis to compare GFP expression from episomal and integrating
vectors containing silencing-resistant promoters: CAG, EF1a, and
PGK1 (18, 19). As shown in Fig. S1, regardless of the promoter
used, GFP expression from integrating HIV-1 vectors was at least
4-fold higher than that of their episomal counterparts. These
findings raised the possibility that gene expression from episomal
HIV-1 vectors is regulated on higher levels than the vectors’ internal
promoter.
HDACi Activate Episomal HIV-1 Vector Genomes Associated with
Histone Modifications Typical of Silenced Chromatin. The general
nature of episomal HIV-1 vector silencing, and the fact that
transcriptional regulation of nonintegrating DNA viruses involves
modifications in chromatin structures organizing these episomal
viral genomes (12), raised the possibility that transcriptionally-
downregulated episomal HIV-1 vectors are also organized into
nucleosomal structures. To test this hypothesis, a chromatin immu-
noprecipitation (ChIP) assay was used to determine whether his-
tone H3, one of the major four histones comprising the nucleosomal
core, is associated with episomal HIV-1 vector genomes. As shown
in Fig. S2A, the association of histone H3 with episomal and
integrating HIV-1 vector genomes was comparable. Although
intriguing, the mere association of histone H3 with episomal vector
genomes could not support the notion that episomal HIV-1 ge-
nomes are organized into chromatin structures. However, direct
evidence for this hypothesis was provided by a micrococcal nuclease
(MNase) assay used on episomal and integrated vector genomes
following transduction of 293T cells with either integrase-proficient
or -deficient HIV-1 vector particles. We show here the nucleoso-
mal-ladder array typical of chromatin structures for both integrated
and episomal vectors (Fig. S3A). As expected, unlike the integrated
vectors, the diluted episomal vector genomes could not be detected
after three passages in culture. The findings that episomal genomes
are organized into chromatin raised the possibility that specific
chromatin modifications render the episomal HIV-1 vector forms
less accessible to host transcriptional machinery. This idea was
supported by a DNaseI sensitivity assay demonstrating that episo-
mal HIV-1 genomes were significantly more resistant to DNaseI
degradation than similar, but integrated, vector genomes (Fig. S3B).
Quantitative-scan analysis of the resulting autoradiogram confirms
that observation (Fig. S3B). Histone modifications, such as acety-
lation of H3 and H4 and di- and trimethylation of H3 lysine 4
(H3-K4), have been associated with open chromatin and gene
activation, while closed chromatin and gene repression have been
associated with trimethylation of H3 lysine 9 (H3-K9) (20). To study
further the mechanism of episomal vector silencing, a ChIP assay
was used to determine which of the above histone modifications
were associated with integrated and episomal HIV-1 vectors at day
3 pt and following 14 days in culture (without being passaged) in
human embryonic fibroblasts (HEFs). The vectors expressed firefly
luciferase under the control of the CMV promoter to correlate
between the vectors’ histone modifications and transgene expres-
sion. As shown in Fig. 1A and Fig. S2A, the histone modification
profile associated with the CMV promoter in the episomal HIV-1
vector genomes is typical of transcriptionally repressed genes,
showing low levels of H3 and H4 acetylation, H3-K4 dimethylation,
and enrichment of trimethylated H3-K9, comparable to the level
found associated with the endogenous (inactive) -globin pro-
moter. In contrast to episomal vectors and similar to the promoter
of the housekeeping gene GAPDH, the CMV promoter in the
integrated HIV-1 vector exhibited a high level of association with
acetylated H3 and H4, dimethylated H3-K4, and minimal associ-
ation with trimethylated H4-K9 (Fig. 1A). To correlate the profile
of chromatin structure, histone modification, and transcriptional
activity of the integrated and episomal vectors, luciferase activity
was measured at days 3 and 14 pt (Fig. 1C). In accordance with the
differences in DNaseI sensitivity and histone modification profiles,
transgene expression from the integrated vector forms was 30- and
40-fold higher than the level of expression obtained from their
episomal counterparts at days 3 and 14, respectively (Fig. 1C).
Importantly, exposure of episomal vector-transduced cells to
HDACi, sodium butyrate (SB) resulted in a roughly 7-fold increase
in episomal transgene expression at day 3 pt (Fig. 1C), with
concomitant increases in H3 and H4 acetylation and H3-K4 dim-
ethylation (Fig. 1A). However, the exposure to SB did not lead to
significant reduction in the level of H3-K9 trimethylation (Fig. 1A
and Fig. S2A). Interestingly, similar HDACi-induced changes in
histone modifications associated with episomal vectors were ob-
served at day 14 pt (Fig. 1B and Fig. S2B), although without a
corresponding increase in episomal transgene expression (Fig. 1C).
These findings indicated that additional layers of regulation, in-
cluding DNA methylation or different histone modifications, ren-
dered the episomal vector silencing resistant to HDACi in a
time-dependent manner. However, DNA methylation analysis of
the CMV promoter by either methylation-sensitive restriction en-
zymes or the bisulfite assay failed to detect methylated CpG
sequences (Fig. S3 C and D).
Episomal HIV-1 Genomes Generated by a Single Round of Infection Are
Associated with Transcriptionally Repressive Histone Modifications
and Are Activated by HDACi. To determine whether histone modi-
fications typical of silenced chromatin are involved in the transcrip-
tional downregulation of integrated and episomal HIV-1 genomes,
SupT1 cells were subjected to a single round of infection with
integrating or integrase-deficient (vD64E) VSV-G-pseudotyped
viruses. Cloning of the firefly luciferase gene in place of the
nef-coding sequence in both viruses allowed direct evaluation of
viral gene expression. As shown in Fig. 2A, although luciferase gene
expression and viral particle release (as measured by p24gag ELISA)
from nonintegrating HIV-1 were significantly lower than the levels
obtained from integrating HIV-1, expression and particle release
from both viruses are increased dramatically upon exposure to 5
mM SB or valproic acid, an HDACi (Fig. 2C and Fig. S4A). Similar
to the CMV promoter of episomal HIV vector genomes, noninte-
grating HIV LTRs were found to be associated with the unmodified
histone H3 and exhibit a profile typical of silent chromatin, includ-
ing low levels of H3 and H4 acetylation and H3-K4 dimethylation,
and high levels of H3-K9 trimethylation (Fig. 2B and Fig. S5). As
expected, the increase in luciferase expression and particle release
from both viruses observed upon exposure to 5 mM SB was
accompanied by a significant increase in histone acetylation and
H3-K4 dimethylation (Fig. 2B and Fig. S5). Interestingly, and in
accordance with results derived from HIV vectors, the observed
high levels of trimethylated-H3-K9 histones were not accompanied
by CpG DNA methylation (Fig. S3E).
Endogenous HDACi in the Form of SCFAs Generated by Normal Gut
Bacteria Activate Transcriptionally Silenced HIV-1 Episomes. The
significant effects of butyric and valproic acids on episomal HIV-1
gene expression and particle release in vitro raised the possibility
that other HDAC-inhibiting SCFAs naturally generated in vivo
could potentially produce the same effect. Endogenously produced
SCFAs are formed in the process of carbohydrate and protein









catabolism by the normal bacterial flora of the gut, as well as by
different bacterial strains in the oral cavity (21, 22). Acetic, propi-
onic, and butyric acids are the predominant SCFAs in the gut, while
other bacteria-derived SCFAs, including formic, valeric, hexanoic,
and heptanoic acids, as well as branched compounds such as
isovaleric, isobutyric, and 2-methylbutyric acids, are formed in
significantly lesser amounts (21). To test the ability of bacteria-
derived SCFAs to upregulate episomal HIV-1 vector gene expres-
sion, integrase-deficient vector particles encoding either GFP or
luciferase were used on 293T cells either in the presence or absence
of various SCFAs (Fig. S4 B and C). Excluding acetic acid and the
branched compound 2-methylbutyric acid, all of the tested bacteria-
derived SCFAs significantly increased episomal-vector gene expres-
sion. Interestingly, SCFAs have demonstrated similar effects on
expression from integrase-proficient HIV-1 (Fig. S4C). Impor-
tantly, analogous effects of SCFAs on episomal HIV-1 expression
and viral particle release were obtained following a single round of
infection in SupT1 cells transduced with the VSV-G-pseudotyped,
integrase-deficient virus vD64E (Fig. 2C). Interestingly, spent me-
dia collected from the SCFA-producing bacteria PG4, a Porphy-
romonas gingivalis strain, and FN, a Fusobacterium nucleatum strain
isolated from the human oral cavity and gut, respectively, also
increased episomal gene expression and particle release (Fig. 2C).
In contrast, spent media collected from Gram-positive Streptococ-
cus mutans, a pathogenic oral bacterium lacking the ability to
produce SCFAs, failed to elicit similar increases in episomal HIV-1
gene expression and particle release (Fig. 2C).
Efficient Replication of Episomal HIV-1 in Primary Monocyte-Derived
Macrophages (MDMs) Exposed to SCFAs. Intrigued by the single-
round-of-infection assays demonstrating the ability of SCFAs to
increase episomal gene expression and enhance viral particle
release from SupT1 cells transduced with integrase-deficient
HIV-1, we investigated whether HDACi, including valproic acid
and various SCFAs formed naturally by gut bacteria, could also
support episomal HIV-1 replication in natural HIV-1 host cells. To
this end, MDMs were infected with either integrating or integrase-
deficient dual-tropic HIV-1 (89.6) in the presence and absence of
HDACi. Viral replication was measured by p24gag ELISA for
















































































































































Fig. 1. Episomal HIV vector genomes are organized into chromatin structures associated with histone modifications typical of silenced chromatin. ChIP assays
were carried out on HEF cells using integrating and nonintegrating vectors (m.o.i. of 2.5 was used), with or without SB treatment, at days 3 (A) and 14 (B) pt and
employing antibodies to dimethylated H3-K4 (i), acetylated H3 and H4 (ii), and trimethylated H3-K9 (iii). The GAPDH and -globin genes were used as references
to active and silent chromatin, respectively. (C) Luciferase assay carried out on HEFs at days 3 and 14 pt (panels 1 and 2, respectively).
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Fig. 3A, integrase-deficient HIV-1 exhibited only limited replica-
tion potential in MDMs. However, a significant (up to 3-fold)
increase in p24gag was observed upon treatment with various
SCFAs. The central role of integration in the HIV-1 life cycle
motivated the development of integrase inhibitors (INi) as an arm
of anti-HIV/AIDS therapy (23). Indeed, recent reports provided
encouraging indications regarding the therapeutic potential of the
INi raltegravir (MK5018) for AIDS patients (24). Intrigued by these
studies, we characterized the effects of SCFAs on HIV-1 replication
in MDMs in the presence of raltegravir. The data presented in Fig.
3B demonstrate that the inhibitory effects of raltegravir on HIV-1
replication (10-fold reduction in p24gag) were partially alleviated by
a number of SCFAs. Interestingly, exposure to HDACi resulted in
an increase in viral particle release following infection of SupT1
cells with wild-type and integrase-deficient HIV-1 particles (Fig.
S6A). However, in contrast to MDMs, episomal particle release was
not sustained in the rapidly dividing SupT1 cells as suggested earlier
(25). Furthermore, these data are in line with an earlier study by
Cara et al. in which nonintegrating HIV-1 was serially passaged in
MDMs (5). Intrigued by these data, we wished to characterize the
specific activity of HIV-1 particles derived from episomal viral
genomes. To this end, HIV-1 particles were generated in SupT1
either in the presence or absence of raltegravir and used on naive
SupT1 cells (Fig. S6B). HIV-1 replication in the presence and
absence of HDACi was determined by measuring p24. As shown in
Fig. S6C, HIV-1 particles generated in the presence of raltegravir
were able to replicate in naive SupT1 cells. However their initial rate
of replication was (first 11 days) slower than the replication of
HIV-1 particles generated in the absence of raltegravir (Fig. S6C).
Interestingly, viral replication was accelerated in the presence of
HDACi (Fig. S6C). These data suggested that although infectious
HIV-1 particles generated from episomal genomes are less infec-
tious than particles generated from integrated provirus templates,
they are capable of initiating the viral life cycle. This notion was
supported by qPCR analysis demonstrating the presence of 1 and
0.075 viral genomes per 100 SupT1 cells infected at m.o.i. of 0.2 with
viral particles generated by wild-type and integrase-deficient
HIV-1, respectively, altogether these findings suggest that episomal
HIV-1 genomes can serve as a template to integration-competent
progenies capable of completing the HIV-1 life cycle.
Productive Crosstalk Between Episomal HIV-1, Nonintegrating HIV-1
Vectors, and Integrase-Proficient HIV-1. Our findings could not rule
out the possibility that various HIV-1 gene products can comple-
ment the deficiencies of episomal viral gene expression. Indeed,
support to this notion was provided by an earlier study demon-
strating the ability of the HIV-1 vpr to activate episomal gene
expression (16). These data suggest that episomal HIV-1 replica-
tion could be supported upon co-infection of a target cell with
integrating viruses. To test this hypothesis, MT4 cells were sub-
jected to consecutive infections with integrase-deficient HIV-1
carrying the luciferase gene in the viral nef coding sequences,
followed 16 h later by infection with the wild-type viral strain
NL4–3. Naive MT4 target cells contained in cell chambers were
Fig. 2. Enhanced SCFA-mediated expression following a single round of infection with nonintegrating HIV-1 in SupT1 cells. (A) (i) Luciferase assay carried out
on SupT1 cells following infection with integrase-proficient (IN-WT) and integrase-deficient (IN-Mut) HIV-1 at m.o.i. of 0.2. (ii) p24gag ELISA of viral particles
released from SupT1-infected cells. The results are presented as PP/mg total protein/copy number/cell. (B) ChIP assay carried out on infected SupT1 cells at day
3 pi employing antibodies directed to H3 (i), dimethylated H3-K4 (ii), acetylated H3 and H4 (iii), and trimethylated H3-K9 (iv) antibodies. LTR, GAPDH, and -globin
regions were analyzed. (C) Luciferase assay (i) and p24gag ELISA (ii) carried out on SupT1 infected with integrase-deficient HIV-1 in the presence of SCFAs-, P.
gingivalis (PG4)-, F. nucleatum (FN)-, or S. mutans bacteria (S1)-derived spent media treatments.









co-cultivated for 4 days with the doubly infected MT4 cells. Mo-
bilization of viral genomes carrying the luciferase gene into the
naive MT4 target cells was determined by real-time PCR. As shown
in Fig. S7A, viral genomes derived from integrase-deficient viruses
containing the luciferase gene were efficiently mobilized into the
naive MT4 cells. However, sequence analysis of the integrase gene
in all mobilized, luciferase-containing viral genomes demonstrated
the wild-type integrase sequence. These finding were in line with an
earlier study by Gelderblom et al. demonstrating recombination
between reverse-transcribed wild-type and integrase-deficient viral
genomes (7). Interestingly, complementation of viral envelope
protein by episomal viral genomes was observed following co-
infection of MT4 cells with VSV-G-pseudotyped, integrating
HIV-1 lacking functional envelope with integrase-deficient virus
encoding functional HIV-1 envelope (Fig. S7A). Next, we sought to
employ a vector mobilization assay as a means to evaluate further
the replication potential of episomal HIV-1.
To this end, MT4 cells transduced with either integrating or
integrase-deficient HIV-1 vector vTK469 were superinfected with
either wild-type or integrase-deficient (D64E) HIV-1 (Fig. S7B).
As expected, mobilization of integrated vector by wild-type NL4–3
virus was highly efficient, resulting in the detection of one vector
genome per 10 target MT4 cell genomes (Fig. S7B). Importantly,
episomal viral genomes supported mobilization of integrated vec-
tors, while episomal vector genomes were efficiently mobilized by
integrating HIV-1, allowing the detection of 15 and 11 mobilized
genomes per 1,000 target cell genomes (Fig. S7B). These data are
in line with an earlier study supporting the notion that productive
crosstalk and complementation could exist between integrating and
episomal HIV-1 genomes (7).
Discussion
In agreement with earlier reports, the data presented here indicate
that gene expression from nonintegrated HIV-1 and HIV vectors
is significantly lower than that of their integrated counterparts (6,
16) and that episomal HIV vector silencing is promoter-
independent. Furthermore, we showed that episomal HIV-1 and
HIV-1 vector genomes are organized into nucleosomal structures,
enriched in histone modifications typical of silenced chromatin, and
thus subjected to layers of gene regulation involved in transcrip-
tional silencing of cellular gene expression. The central role of
viral-genome chromatinization on gene expression and the life cycle
of nonintegrating DNA viruses, including SV40, EBV, HSV, AAV,
HBV, and others, has been well documented (11–13). In particular,
a number of research groups focusing on the early stages of the
herpes viral life cycle have described a competition between cellular
epigenetic silencing of viral genes and viral inhibition of HDAC
activity mediated by ICP0 and Us3, as well as IE1 and IE2 of HSV1
and CMV, respectively, to enable the expression of viral genes (26,
27). In analogy to this phenomenon, we showed that HDACi
significantly increased gene expression from episomal vector and
viral forms following transduction of various cell lines, as well as
primary MDMs, with integrase-deficient HIV-1-based vectors and
HIV-1. Furthermore, upon exposure to HDACi, a substantial
increase in HIV-1 particle release was observed from MDMs
following multiple rounds of HIV-1 infection in the presence of the
clinically used INi raltegravir. Importantly, the increase in episomal
HIV-1 gene expression was accompanied by a concomitant in-
crease in episomal viral and vector genomes associated with histone
modifications typical of active chromatin. Notwithstanding the
increase in episomal expression, the exposure to HDACi did not
result in a significant decrease in the association of episomal
genomes with trimethylated H3-K9 typical of silent chromatin.
Thus, the role of this modification in marking episomal HIV-1
genomes for transcriptional silencing should be further investigated,
especially since trimethylated H3-K9 was shown to be directly
involved in DNA methylation (28). In this regard, CpG sequences
in episomal HIV-1 vectors were found not methylated; however, the
notion that additional chromatin modifications and layers of reg-
ulation are involved in episomal HIV-1 silencing was supported by
the fact that at day 14 pt the HDAC inhibitors mediated an increase
in H3 and H4 histone acetylation associated with episomal vectors
that was not accompanied by an increase in episomal transgene
expression. These results are in accord with earlier data demon-
strating efficient silencing of HIV-1 vectors independent of DNA
methylation (29).
Although it is possible that the silencing of HIV-1 includes all
forms of reverse-transcribed HIV-1 genomes (including the linear
form required for integration), it appears that, through integration
into active-chromatin regions associated with histone modifications
typical of active chromatin, the silencing of proviral HIV-1 genomes
is partly alleviated (30, 31). Indeed, particle release and gene
expression from integrated HIV-1 and HIV-1 vectors, which were
always significantly higher than the levels obtained from their
nonintegrating counterparts, were further increased upon exposure
of viral/vector transduced cells to HDACi.
The replication timing of proviral HIV-1 genomes has not been
characterized. However, the favored HIV-1 integration sites in
active transcription units suggest that integrated HIV-1 and HIV-1
vector genomes replicate in early S-phase, which may further
enhance proviral gene expression (32).
Two sources of HDACi can be considered potential means by
which epigenetic silencing of HIV-1 gene expression might be
alleviated: (i) HDACi encoded by other viruses co-infecting similar
HIV-1 targets and (ii) HDAC inhibitors in the form of SCFAs
generated by the gut’s normal bacterial flora. In line with the
second possibility, a recent study demonstrated that bacteria-
derived SCFAs upregulated KSHV replication (22). Here we
provide evidence that SCFAs, similar to those generated in the gut
(21), significantly increase transgene expression from episomal
HIV-1 vectors, as well as gene expression, particle release, and
replication of integrase-deficient and wild-type HIV-1 from MDMs
and SupT1 cells in the presence of raltegravir, the INi currently in
clinical trials for HIV-1 treatment (23). These findings are in line
Fig. 3. Effects of SCFAs on integrase-deficient HIV-1 replication in MDMs. (A)
MDMs infected by integrase-deficient HIV-1 (IN-Mut) at m.o.i. of 0.5, in the
presence of 1 mM propionic (PROP), valproic (VPA), and heptanoic (HEPT)
acids for 0 to 20 days, were subjected to p24gag ELISA. (B) p24gag ELISA carried
out on MDMs infected by wild-type HIV-1, incubated with raltegravir (35 nM),
and treated with or without SCFAs. The results are presented as ng p24/mL.
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with a recent publication demonstrating activation of latent HIV-1
provirus by bacteria-derived SCFAs (33). Thus, these data provide
a direct indication that SCFAs-mediated activation of episomal and
integrated HIV-1 plays a major role in the early phase of HIV-1
infection, during which CD4 cells in the gut-associated lymphatic
tissue (GALT) are first to be lost and are the last to be recovered
upon HAART (34). Interestingly enough, nonintegrated HIV-1
genomes have been found to be the most prevalent form of HIV-1
DNA in resting CD4 T cells and macrophages undergoing
HAART treatment (1). Thus, the finding reported here suggests
that nonintegrating HIV-1 forms may serve as an additional
reservoir in AIDS patients.
Aware of the fact that significant numbers of HIV-1-infected
cells contain more than one viral genome (35), we demonstrate a
viable crosstalk between integrated and episomal HIV-1 forms,
which, similar to an earlier report, allowed recombination between
integrase-deficient and wild-type viral genomes (7). Overall, this
study demonstrates that chromatinized episomal HIV-1 genomes
are subject to epigenetic silencing, which can be alleviated by
HDACi, including SCFAs generated by the normal bacterial flora
of the gut and thus, strongly indicates that episomal HIV-1 forms
and SCFAs could play an important role in the early phases of
HIV-1 infection, especially when the initial viral load is low.
Importantly, the lymphotoxic properties of SCFAs observed by
several laboratories (36) may contribute to the rapid decline in
CD4 cell counts in the gut during early-phase HIV infection.
Furthermore, the effects of bacteria-derived SCFAs on viral rep-
lication are probably extended outside the GALT, upon damage to
the gut mucosa and leakage of bacterial products into the circula-
tory system.
Methods
Plasmids and Virus Production. Vectors and viruses were generated through
transient transfection of 293T cells (37). pTK113 and pTK469, respectively, and
NRF, NRF-E152A, and pTK939 (NRF-D64E) packaging plasmids have been
described previously (10, 17). All other plasmids used in this study are described
in the SI Methods.
Cells and Infection. 293T, HEFs, MT4, vTK469-expressing MT4, Jurkat, Jurkat-KS,
SupT1, and MDM cells were used in this study. MDMs were also supplemented
with GM-CSF, as described in (SI Methods). For multiple-round infections, cells
were infected at a concentration of 25–50 ng p24/million target cells, and virus
was harvested every 4 days, while for single-round infections, cells were infected
at an m.o.i. of 0.2 and harvested after 3 days. For transductions, cells received
vector at an m.o.i. of 0.2–2.5 and were harvested after 3 and 14 days.
p24gag ELISA. Vector and virus particle number were measured using the National
Institutes of Health p24 Antigen Capture Assay kit. Results are presented in
physical particles (PP)/mg protein/copy number/cell (described below), or in ng
p24/mL. PP was calculated as 1 ng; p24 is equal to 4,000 PP.
Luciferase Assay. Luciferase expression was measured using a Victor3 multilabel
counter (PerkinElmer). Results are represented as relative light units (RLU)/mg
protein/copy number/cell.
Chromatin Immunoprecipitation. The ChIP assay was performed as described (38)
(see also SI Methods).
Real-Time PCR. DNA for real-time PCR was prepared as described (10).
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